New approaches and targets in advanced colorectal cancer

Eur J Cancer. 2009 Sep:45 Suppl 1:79-88. doi: 10.1016/S0959-8049(09)70019-X.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Oncogene Protein v-akt / antagonists & inhibitors
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinases / metabolism
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors
  • Receptor, Platelet-Derived Growth Factor alpha / antagonists & inhibitors
  • Receptors, Somatomedin / antagonists & inhibitors
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • TNF-Related Apoptosis-Inducing Ligand / antagonists & inhibitors
  • TOR Serine-Threonine Kinases
  • src-Family Kinases / antagonists & inhibitors

Substances

  • Phosphoinositide-3 Kinase Inhibitors
  • Receptors, Somatomedin
  • TNF-Related Apoptosis-Inducing Ligand
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2
  • Protein Kinases
  • MTOR protein, human
  • ErbB Receptors
  • Proto-Oncogene Proteins c-met
  • Receptor, Platelet-Derived Growth Factor alpha
  • Receptors, Vascular Endothelial Growth Factor
  • src-Family Kinases
  • Oncogene Protein v-akt
  • TOR Serine-Threonine Kinases